Morning Briefing
Summaries of health policy coverage from major news organizations
Moderna Vaccine Protection Is Lower Against Omicron; Booster Helps, Study Finds
NPR: Moderna Vaccine No Match For Omicron Except With Booster, Study Finds
There's more mixed news about the power of vaccines to protect people against the omicron variant — this time about the Moderna vaccine. A preliminary study made public Wednesday studied blood samples in the lab from 30 people who had gotten two Moderna shots, and it found that the antibodies in their blood are at least about 50 times less effective at neutralizing the omicron variant of the coronavirus. Previous research had indicated the Pfizer-BioNTech vaccine is also less protective against omicron. (Stein, 12/15)
The Hill: Study Suggests Antibodies From Two Moderna Doses Less Effective At Neutralizing Omicron
A preprint study published Wednesday indicated that the antibodies in blood samples from recipients of two Moderna doses were less effective at neutralizing the omicron variant, suggesting an increased risk of symptomatic breakthrough cases. ... They found these antibodies in two-dose Moderna recipients were at least 50 times less effective at neutralizing the omicron strain, which “could lead to an increased risk of symptomatic breakthrough infections.” (Coleman, 12/15)
And researchers continue to examine how the Moderna jab holds up against delta —
CIDRAP: COVID MRNA Vaccines Lose Strength Against Delta Over Time
Two new studies highlight waning mRNA COVID-19 efficacy against infection against the Delta (B1617.2) variant, with one showing that two doses of the Moderna vaccine were highly effective against all variants but that protection against Delta fell over time since vaccination. The other reveals a precipitous drop in mRNA vaccine effectiveness after the emergence of Delta among an older group of US veterans. (Van Beusekom, 12/15)
